Remove 2022 Remove Insurance Remove Pharmaceutical Companies
article thumbnail

STAT+: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion

STAT

billion combined last year, compared with $4 billion in 2022. million in 2022. The heads of pharmaceutical companies and medical device firms continued to sit at the top as their patented products reaped the biggest windfalls.  But the biggest names in health care still made $3.5

article thumbnail

Mounjaro generic availability, cost, and more

The Checkup by Singlecare

Dr. Ali says both those drugs have been around at least 12 years longer than Mounjaro, which was approved for diabetes management in 2022 (it is still not FDA approved for obesity or weight management). In the case of Mounjaro , the pharmaceutical company Eli Lilly holds a patent for both the medication and its injection delivery device.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

Opinion: STAT+: What Mark Cuban gets wrong about prescription drugs

STAT

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. Meanwhile, generic drug companies saved the U.S. roughly $2.6

article thumbnail

STAT+: Pharmalittle: We’re reading about China detaining AstraZeneca staff, pharma layoffs, and more

STAT

The company was previously taken to task by Chinese authorities in 2022 for allegedly tampering with the gene-testing results of cancer patients to make treatment eligible for reimbursement by China’s state-run medical insurance. The number of layoffs in the U.S. Continue to STAT+ to read the full story…

article thumbnail

Is Nucala covered by Medicare?

The Checkup by Singlecare

Health insurance coverage and Medicare prescription drug plans might cover a substantial portion of the price. However, a patient’s out-of-pocket costs are also based on “whether they have satisfied their deductible and what kind of copays or co-insurance their policy carries along with it,” says Michael O. Does Medicare cover Nucala?

article thumbnail

Five things to watch as the Biosimilars market heats up in 2022

pharmaphorum

And already in the first quarter of 2022, the FDA approved a third filgrastim biosimilar, Releuko. Here are five things I have my eye on in 2022. Coherus BioSciences—who also has an approved adalimumab and pegfilgrastim product— is anticipating action by the FDA in August 2022 on its ranibizumab candidate.

FDA 59